Compositions and methods for treating psoriasis
OwnerKeting Chu, Changyu Wanginventors
Life of this patent
Estimating the term…
Abstract
CD40 antagonists are used to prepare compositions, including pharmaceutical compositions, for treating autoimmune and neoplastic diseases in a mammal. The CD40 antagonist compositions are useful for reversing or substantially diminishing such autoimmune diseases as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis and psoriasis.
Claims23
A composition for treating an autoimmune disease, comprising a therapeutically effective amount of a CD40 antagonist in a phannaceutically acceptable carrier.
A method of treating a mammal afflicted with an autoimmune disease, comprising administering to said mammal a therapeutically effective amount of a CD40 antagonist thereby reducing the severity of said autoimmune disease.
A method of treating a mammal afflicted with a neoplastic disease, comprising administering to said mammal a therapeutically effective amount of a CD40 antagonist thereby reducing the severity of said neoplastic disease.
A method of treating a mammal afflicted with psoriasis, comprising administering to said mammal a therapeutically effective amount of a CD40 antagonist.
Dependencies are inferred from the claim text.